Community Schedule

Enter at least 4 characters

2 results showing for: 'octreotide'

  1. Endocrine Therapy
Octreotide    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 181.
  • Inj 100 mcg per ml, 1 ml vial
    • Brand Fully subsidised brand. Omega Unapproved medicine supplied under Section 29.
    • Pharmacode2687275
    • Subsidy $48.50
    • Measure / Qty per 5
  • Inj 50 mcg per ml, 1 ml ampoule
    • Brand Fully subsidised brand. Octreotide GH Unapproved medicine supplied under Section 29.
    • Pharmacode2595907
    • Subsidy $27.58
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Max Health
    • Pharmacode2629534
    • Subsidy $27.58
    • Measure / Qty per 5
  • Inj 100 mcg per ml, 1 ml ampoule
    • Brand Fully subsidised brand. Octreotide GH Unapproved medicine supplied under Section 29.
    • Pharmacode2595885
    • Subsidy $32.71
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Max Health
    • Pharmacode2629518
    • Subsidy $32.71
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Sun Pharma Unapproved medicine supplied under Section 29.
    • Pharmacode2669382
    • Subsidy $32.71
    • Measure / Qty per 5
  • Inj 500 mcg per ml, 1 ml ampoule
    • Brand Fully subsidised brand. Octreotide GH Unapproved medicine supplied under Section 29.
    • Pharmacode2595893
    • Subsidy $113.10
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Max Health
    • Pharmacode2629526
    • Subsidy $113.10
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Sun Pharma Unapproved medicine supplied under Section 29.
    • Pharmacode2669390
    • Subsidy $113.10
    • Measure / Qty per 5

For GnRH ANALOGUES – refer to HORMONE PREPARATIONS, Trophic Hormones, page 91

  1. Endocrine Therapy
Octreotide long-acting    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 181.
- Special Authority SA2119 -- Retail pharmacy
  • Inj depot 10 mg prefilled syringe
    • Brand Fully subsidised brand. Sandostatin LAR
    • Pharmacode2150832
    • Subsidy $438.40
    • Measure / Qty per 1
    • Brand Fully subsidised brand. Octreotide Depot Teva
    • Pharmacode2615320
    • Subsidy $439.97
    • Measure / Qty per 1
    Sandostatin LAR to be Principal Supply on 1 December 2024

    (Octreotide Depot Teva Inj depot 10 mg prefilled syringe to be delisted 01 December 2024)
  • Inj depot 20 mg prefilled syringe
    • Brand Fully subsidised brand. Sandostatin LAR
    • Pharmacode2150840
    • Subsidy $583.70
    • Measure / Qty per 1
    • Brand Fully subsidised brand. Octreotide Depot Teva
    • Pharmacode2615339
    • Subsidy $647.03
    • Measure / Qty per 1
    Sandostatin LAR to be Principal Supply on 1 December 2024

    (Octreotide Depot Teva Inj depot 20 mg prefilled syringe to be delisted 01 December 2024)
  • Inj depot 30 mg prefilled syringe
    • Brand Fully subsidised brand. Sandostatin LAR
    • Pharmacode2150859
    • Subsidy $670.80
    • Measure / Qty per 1
    • Brand Fully subsidised brand. Octreotide Depot Teva
    • Pharmacode2615347
    • Subsidy $718.55
    • Measure / Qty per 1
    Sandostatin LAR to be Principal Supply on 1 December 2024

    (Octreotide Depot Teva Inj depot 30 mg prefilled syringe to be delisted 01 December 2024)
SA2119 – Octreotide long-acting

For GnRH ANALOGUES – refer to HORMONE PREPARATIONS, Trophic Hormones, page 91

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply



Email enquiry@pharmac.govt.nz to provide feedback: compliments, suggestions and complaints.